4 ms·
This is really something better left for pharmaceutical giants given how much R&D would cost and the time to market. The amount of time to see a return on the i
by moose_man 3y ago
This is really something better left for pharmaceutical giants given how much R&D would cost and the time to market. The amount of time to see a return on the investment makes it impractical for a startup. Weight-loss drugs are going to be incredibly lucrative but it took long term research into treating diabetes to make any practical progress. If we get a treatment for height it will likely come from a similar long term adjacent research.
- dave4420 3y agoI thought pharmaceutical giants did their R&D these days by buying startups that had already done the hard work? And which in turn had been spun out of a university department that had done the basic research?